Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family

Cell Stem Cell

Volumn 3, Issue 4, 2008, Pages 416-428

  Viatour, Patrick ^a,e   Somervaille, Tim C ^a   Venkatasubrahmanyam, Shivkumar ^a   Kogan, Scott ^c   McLaughlin, Margaret E ^b   Weissman, Irving L ^a   Butte, Atul J ^a   Passegué, Emmanuelle ^d   Sage, Julien ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

CELLCYCLE; HUMDISEASE; STEMCELL

Indexed keywords

PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL EXPANSION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; GENE INACTIVATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; LYMPHOID CELL; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; STEM CELL MOBILIZATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID PROGENITOR CELLS; MYELOPROLIFERATIVE DISORDERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130;

MUS;

EID: 52949114971     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2008.07.009     Document Type: Article

References (44)

1. Barista I., Romaguera J.E., and Cabanillas F. Mantle-cell lymphoma. Lancet Oncol. 2 (2001) 141-148
2. Chen J., Gorman J.R., Stewart V., Williams B., Jacks T., and Alt F.W. Generation of normal lymphocyte populations by Rb-deficient embryonic stem cells. Curr. Biol. 3 (1993) 405-413
3. Cheng T., Rodrigues N., Dombkowski D., Stier S., and Scadden D.T. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6 (2000) 1235-1240
4. Cheng T., Rodrigues N., Shen H., Yang Y., Dombkowski D., Sykes M., and Scadden D.T. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287 (2000) 1804-1808
5. Cobrinik D., Lee M.H., Hannon G., Mulligan G., Bronson R.T., Dyson N., Harlow E., Beach D., Weinberg R.A., and Jacks T. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10 (1996) 1633-1644
6. Daria D., Filippi M.D., Knudsen E.S., Faccio R., Li Z., Kalfa T., and Geiger H. The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress. Blood 111 (2008) 1894-1902
7. Fasano C.A., Dimos J.T., Ivanova N.B., Lowry N., Lemischka I.R., and Temple S. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 1 (2007) 87-99
8. Fleming W.H., Alpern E.J., Uchida N., Ikuta K., Spangrude G.J., and Weissman I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122 (1993) 897-902
9. Geng Y., Yu Q., Sicinska E., Das M., Schneider J.E., Bhattacharya S., Rideout W.M., Bronson R.T., Gardner H., and Sicinski P. Cyclin E ablation in the mouse. Cell 114 (2003) 431-443
10. Hirasawa R., Shimizu R., Takahashi S., Osawa M., Takayanagi S., Kato Y., Onodera M., Minegishi N., Yamamoto M., Fukao K., et al. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195 (2002) 1379-1386
11. Iavarone A., King E.R., Dai X.M., Leone G., Stanley E.R., and Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 432 (2004) 1040-1045
12. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006) 421-426
13. Kozar K., Ciemerych M.A., Rebel V.I., Shigematsu H., Zagozdzon A., Sicinska E., Geng Y., Yu Q., Bhattacharya S., Bronson R.T., et al. Mouse development and cell proliferation in the absence of D cyclins. Cell 118 (2004) 477-491
14. Krimpenfort P., Ijpenberg A., Song J.Y., van der Valk M., Nawijn M., Zevenhoven J., and Berns A. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448 (2007) 943-946
15. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
16. LeCouter J.E., Kablar B., Hardy W.R., Ying C., Megeney L.A., May L.L., and Rudnicki M.A. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene. Mol. Cell. Biol. 18 (1998) 7455-7465
17. Lee M.H., Williams B.O., Mulligan G., Mukai S., Bronson R.T., Dyson N., Harlow E., and Jacks T. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10 (1996) 1621-1632
18. Leoncini L., Bellan C., and De Falco G. Retinoblastoma gene family expression in lymphoid tissues. Oncogene 25 (2006) 5309-5314
19. Malumbres M., Sotillo R., Santamaria D., Galan J., Cerezo A., Ortega S., Dubus P., and Barbacid M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118 (2004) 493-504
20. Maru Y. Molecular biology of chronic myeloid leukemia. Int. J. Hematol. 73 (2001) 308-322
21. Metcalf D. On hematopoietic stem cell fate. Immunity 26 (2007) 669-673
22. Mihara K., Chowdhury M., Nakaju N., Hidani S., Ihara A., Hyodo H., Yasunaga S., Takihara Y., and Kimura A. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 107 (2006) 305-308
23. Miyamoto K., Araki K.Y., Naka K., Arai F., Takubo K., Yamazaki S., Matsuoka S., Miyamoto T., Ito K., Ohmura M., et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1 (2007) 101-112
24. Oguro H., Iwama A., Morita Y., Kamijo T., van Lohuizen M., and Nakauchi H. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J. Exp. Med. 203 (2006) 2247-2253
25. Orford K.W., and Scadden D.T. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 9 (2008) 115-128
26. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
27. Passegue E., Wagers A.J., Giuriato S., Anderson W.C., and Weissman I.L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202 (2005) 1599-1611
28. Rossi D.J., Jamieson C.H., and Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 132 (2008) 681-696
29. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
30. Sankaran V.G., Orkin S.H., and Walkley C.R. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 22 (2008) 463-475
31. Santamaria D., Barriere C., Cerqueira A., Hunt S., Tardy C., Newton K., Caceres J.F., Dubus P., Malumbres M., and Barbacid M. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448 (2007) 811-815
32. Spike B.T., and Macleod K.F. The Rb tumor suppressor in stress responses and hematopoietic homeostasis. Cell Cycle 4 (2005) 42-45
33. Spike B.T., Dirlam A., Dibling B.C., Marvin J., Williams B.O., Jacks T., and Macleod K.F. The Rb tumor suppressor is required for stress erythropoiesis. EMBO J. 23 (2004) 4319-4329
34. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128 (2007) 325-339
35. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., and Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 445 (2007) 661-665
36. Walkley C.R., and Orkin S.H. Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 103 (2006) 9057-9062
37. Walkley C.R., Shea J.M., Sims N.A., Purton L.E., and Orkin S.H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129 (2007) 1081-1095
38. Wikenheiser-Brokamp K.A. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell. Mol. Life Sci. 63 (2006) 767-780
39. Ye M., Iwasaki H., Laiosa C.V., Stadtfeld M., Xie H., Heck S., Clausen B., Akashi K., and Graf T. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19 (2003) 689-699
40. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., and Morrison S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (2006) 475-482
41. Yu H., Yuan Y., Shen H., and Cheng T. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 107 (2006) 1200-1206
42. Yuan Y., Yu H., Boyer M.J., Song X., Cao S., Shen H., and Cheng T. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice. Cancer Res. 66 (2006) 343-351
43. Zhang J., Grindley J.C., Yin T., Jayasinghe S., He X.C., Ross J.T., Haug J.S., Rupp D., Porter-Westpfahl K.S., Wiedemann L.M., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441 (2006) 518-522
44. Zon L.I. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 453 (2008) 306-313